Editorial Commentary
Long-term HIF-2α inhibition in von Hippel-Lindau disease: insights from LITESPARK-004
Translational Andrology and Urology
2025;
14
(10)
:2781-2785
.
(31 October 2025)
Checkmate 274: expanding treatment options for muscle-invasive bladder cancer
Translational Andrology and Urology
2025;
14
(10)
:2786-2791
.
(31 October 2025)
Original Article
Association between erectile dysfunction and relative fat mass in adult men in the United States
Translational Andrology and Urology
2025;
14
(10)
:2792-2804
.
(31 October 2025)
Combining single-cell and bulk RNA sequencing data to create a reliable prognostic model for predicting clear-cell renal cell carcinoma progression
Translational Andrology and Urology
2025;
14
(10)
:2805-2826
.
(31 October 2025)
Association between social determinants of health and erectile dysfunction: insights from a nationally representative US sample
Translational Andrology and Urology
2025;
14
(10)
:2827-2843
.
(31 October 2025)
Predicting bone metastasis and high-grade Gleason scores in prostate cancer: a retrospective study integrating clinical features and magnetic resonance imaging radiomics
Translational Andrology and Urology
2025;
14
(10)
:2844-2858
.
(31 October 2025)
Histological prostatitis and its influence on benign prostatic hyperplasia: a systematic review and meta-analysis
Translational Andrology and Urology
2025;
14
(10)
:2859-2872
.
(31 October 2025)
A log odds of positive lymph nodes (LODDS)-based nomogram for survival prediction in elderly bladder cancer patients after radical cystectomy: development and validation using SEER and Chinese cohorts
Translational Andrology and Urology
2025;
14
(10)
:2873-2884
.
(31 October 2025)
Myeloperoxidase inhibits prostate cancer progression, suppresses the PI3K/AKT signaling pathway and reshapes the immune microenvironment
Translational Andrology and Urology
2025;
14
(10)
:2885-2901
.
(31 October 2025)
Ursolic acid sensitizes bladder cancer to gemcitabine chemotherapy by concurrently targeting PI3K/AKT and JNK pathways
Translational Andrology and Urology
2025;
14
(10)
:2902-2916
.
(31 October 2025)
Clinicopathological features and prognostic factors of clear cell papillary renal cell tumor: a retrospective population-based analysis
Translational Andrology and Urology
2025;
14
(10)
:2917-2926
.
(31 October 2025)
Association between delayed graft function and cytomegalovirus infection after renal transplant
Translational Andrology and Urology
2025;
14
(10)
:2927-2934
.
(31 October 2025)
Mean platelet volume is a predictor for abscess formation in patients with epididymitis
Translational Andrology and Urology
2025;
14
(10)
:2935-2943
.
(31 October 2025)
Feasibility analysis of generative artificial intelligence tools as a means of medical science popularization on urological diseases
Translational Andrology and Urology
2025;
14
(10)
:2944-2952
.
(31 October 2025)
Single-cell multi-omics and spatial transcriptomics reveal the transcriptional regulatory landscape of clear cell renal cell carcinoma
Translational Andrology and Urology
2025;
14
(10)
:2953-2974
.
(31 October 2025)
Impact of preoperative SARS-CoV-2 infection on post-prostatectomy urinary continence and erectile function
Translational Andrology and Urology
2025;
14
(10)
:2975-2984
.
(31 October 2025)
Association of Geriatric Nutritional Risk Index with erectile dysfunction in the elderly population
Translational Andrology and Urology
2025;
14
(10)
:2985-2994
.
(31 October 2025)
Preliminary study of ultrasound-guided ilioinguinal-iliohypogastric nerve block in performing low ligation of the spermatic vein
Translational Andrology and Urology
2025;
14
(10)
:2995-3002
.
(31 October 2025)
Decoding the ceRNA regulatory landscape: a comprehensive transcriptomic analysis of ncRNA-driven bladder fibrosis following spinal cord injury
Translational Andrology and Urology
2025;
14
(10)
:3003-3022
.
(31 October 2025)
Body mass index mediates the association between heavy metal exposure and overactive bladder risk: insights from a nationally representative cross-sectional study using explainable machine learning
Translational Andrology and Urology
2025;
14
(10)
:3023-3041
.
(31 October 2025)
Erectile dysfunction increases the risk of stroke: evidence from NHANES and Mendelian randomization analysis
Translational Andrology and Urology
2025;
14
(10)
:3042-3052
.
(31 October 2025)
Age-related variations in thyroid function hormones indicate the risk of prostate cancer: evidence from a nationally representative dataset
Translational Andrology and Urology
2025;
14
(10)
:3053-3063
.
(31 October 2025)
Immunotherapy research for prostate cancer from 2000 to 2024: a bibliometric and visualization analysis
Translational Andrology and Urology
2025;
14
(10)
:3064-3087
.
(31 October 2025)
Clinical features and management strategies of ectopic kidney: a 25-year single-center retrospective analysis
Translational Andrology and Urology
2025;
14
(10)
:3088-3096
.
(31 October 2025)
Integrating transcriptomics, single-cell omics, and deep learning-based histopathological features to identify OLFML3 in bladder cancer
Translational Andrology and Urology
2025;
14
(10)
:3097-3113
.
(31 October 2025)
Inflammatory index-based nomogram for risk stratification of erectile dysfunction: a cross-sectional study with dual-cohort validation and mendelian randomization analysis
Translational Andrology and Urology
2025;
14
(10)
:3114-3132
.
(31 October 2025)
Proportional, but not absolute, intake of appropriate plant protein is associated with a reduced risk of chronic kidney disease: a cross-sectional study based on NHANES 2005–2018
Translational Andrology and Urology
2025;
14
(10)
:3133-3143
.
(31 October 2025)
Association between early age at menarche and overactive bladder risk in women: insights from NHANES and Mendelian randomization analysis
Translational Andrology and Urology
2025;
14
(10)
:3144-3158
.
(31 October 2025)
Icariside II attenuates renal fibrosis through mTOR signaling modulation: an integrated approach combining network pharmacology, molecular dynamics, and in vitro validation
Translational Andrology and Urology
2025;
14
(10)
:3159-3180
.
(31 October 2025)
Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC
Translational Andrology and Urology
2025;
14
(10)
:3181-3193
.
(31 October 2025)
Analysis of risk factors for kidney stones in patients with hyperuricemia: a cross-sectional study based on NHANES
Translational Andrology and Urology
2025;
14
(10)
:3194-3202
.
(31 October 2025)
Association between tacrolimus intrapatient variability and clinical outcomes in kidney transplantation: a retrospective cohort study
Translational Andrology and Urology
2025;
14
(10)
:3203-3211
.
(31 October 2025)
Integrated transcriptomics, proteomics, and metabolomics to uncover inflammatory-metabolic crosstalk and key molecules in a mouse model of hyperoxaluria-induced kidney injury
Translational Andrology and Urology
2025;
14
(10)
:3212-3229
.
(31 October 2025)
Efficacy analysis of modified circumcision in the treatment of pediatric concealed penis
Translational Andrology and Urology
2025;
14
(10)
:3230-3245
.
(31 October 2025)
Pre-treatment C-reactive protein level is a prognostic marker of patients treated with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis
Translational Andrology and Urology
2025;
14
(10)
:3246-3255
.
(31 October 2025)
Associations between metabolic obesity phenotypes and prostate cancer in the U.S. population: a cross-sectional study
Translational Andrology and Urology
2025;
14
(10)
:3256-3267
.
(31 October 2025)
Sparing urethra in women at the time of cystectomy: retrospective comparison of cystectomies with and without urethrectomy
Translational Andrology and Urology
2025;
14
(10)
:3268-3276
.
(31 October 2025)
Identification of molecular subtypes and prognostic risk model of glucocorticoid-related lncRNAs in bladder cancer to evaluate prognosis and immunological characteristics
Translational Andrology and Urology
2025;
14
(10)
:3277-3297
.
(31 October 2025)
Personalized radiotherapy benefit prediction in non-surgically managed prostate adenocarcinoma: a prognostic nomogram for survival risk stratification
Translational Andrology and Urology
2025;
14
(10)
:3298-3308
.
(31 October 2025)
Surgical Technique
Excisional urethroplasty and the abdominoperineal approach to posterior urethral stenosis: surgical techniques and considerations for the radiated patient
Translational Andrology and Urology
2025;
14
(10)
:3309-3320
.
(31 October 2025)
Large stone in neobladder: percutaneous neocystolithotomy
Translational Andrology and Urology
2025;
14
(10)
:3321-3327
.
(31 October 2025)
Review Article
Management of pelvic fracture urethral injury
Translational Andrology and Urology
2025;
14
(10)
:3328-3341
.
(31 October 2025)
Robot-assisted reconstruction of posterior urethral stenosis: surgical techniques, graft use, and clinical outcomes
Translational Andrology and Urology
2025;
14
(10)
:3342-3353
.
(31 October 2025)
Management of prostatic necrosis and the devastated bladder outlet—a narrative review
Translational Andrology and Urology
2025;
14
(10)
:3354-3366
.
(31 October 2025)
Complications and management of penile enhancement procedures
Translational Andrology and Urology
2025;
14
(10)
:3367-3376
.
(31 October 2025)
Contemporary management of radiation-associated posterior urethral stenosis: a narrative review
Translational Andrology and Urology
2025;
14
(10)
:3377-3386
.
(31 October 2025)
Antidiabetic agents and male fertility: unraveling the impact of glucose-lowering therapies on sperm quality in diabetic males—a narrative review
Translational Andrology and Urology
2025;
14
(10)
:3387-3401
.
(31 October 2025)
Pharmacotherapy for bladder spasm and irritative lower urinary tract symptoms associated with intravesical therapy for bladder cancer: a review of available evidence
Translational Andrology and Urology
2025;
14
(10)
:3402-3412
.
(31 October 2025)
Prophylactic adjuvant therapy for postoperative recurrence of urethral stricture: a narrative review
Translational Andrology and Urology
2025;
14
(10)
:3413-3427
.
(31 October 2025)
Case Report
Robot-assisted ureteral reconstruction using buccal mucosal graft for traumatic complete ureteral avulsion: a rare case report
Translational Andrology and Urology
2025;
14
(10)
:3428-3436
.
(31 October 2025)
